Yangmei Chemical Co., Ltd.

Yangmei Chemical Co. faced significant stock volatility on March 20, 2026, with an 18.43% decline. Despite a one-month gain of 25.82% and a yearly increase of 79.91%, the company struggles with negative cash flow, high debt, and declining net sales, raising concerns about its long-term growth prospects.

Yangmei Chemical Co., a key player in specialty chemicals, saw its stock decline despite a strong annual performance, significantly outpacing the broader market. The company faces financial challenges, including a high debt-to-equity ratio and recent declines in net sales and operating cash flow, raising concerns about its long-term stability.

Yangmei Chemical Co. has shown remarkable stock performance, gaining over 10% on March 17, 2026, and achieving significant increases over various time frames. However, the company faces challenges such as operating losses and a high debt-to-equity ratio, raising concerns about its long-term growth potential amidst market volatility.

Yangmei Chemical Co. has seen a notable increase in its stock performance, significantly outperforming the China Shanghai Composite index over various time frames. Despite impressive short-term gains, the company faces challenges such as operating losses and a declining long-term growth outlook, reflecting the volatility in the specialty chemicals sector.

Yangmei Chemical Co. has seen a notable rise in its stock price, achieving significant gains over various time frames, including a 94.69% increase over the past year. However, the company faces challenges such as operating losses and a high debt-to-equity ratio, raising concerns about its long-term growth prospects.

Yangmei Chemical Co. has demonstrated strong stock performance, significantly outperforming the China Shanghai Composite in various time frames. Despite impressive gains over the past year, the company faces challenges such as operating losses and a declining sales trend, raising concerns about its long-term growth potential.

Yangmei Chemical Co. has experienced notable short-term gains, with a 6.45% increase today and a 31.52% rise year-to-date. However, the company faces long-term challenges, including declining net sales, operating losses, a high debt-to-equity ratio, and negative return on equity, raising concerns about its financial health.